EP 4076183 A4 20240124 - COMPOSITIONS AND METHODS FOR CALIBRATION AND QUALITY CONTROL
Title (en)
COMPOSITIONS AND METHODS FOR CALIBRATION AND QUALITY CONTROL
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR KALIBRIERUNG UND QUALITÄTSKONTROLLE
Title (fr)
COMPOSITIONS ET PROCÉDÉS D'ÉTALONNAGE ET DE CONTRÔLE DE QUALITÉ
Publication
Application
Priority
- US 201962950796 P 20191219
- US 2020065997 W 20201218
Abstract (en)
[origin: WO2021127424A1] The disclosure features calibration fluids that include a plurality of beads, such as cellulose, silica, poly(methyl-methacrylate) (PMMA), melamine, cross-linked agarose, polyvinylacetate (PVA), and/or polystyrene beads, where the beads are sized and colored to represent at least one type of blood cell; and a carrier fluid, that can include a polymer or polymerizing matrix, e.g., a water-soluble resin, e.g., an acrylic or polyurethane water-soluble resin or a starch or a cellulose, serum, and/or one or more or sugars. The disclosure also features methods of using the calibration fluids to calibrate automated sample preparation systems, such as automated hematology analyzer systems, e.g., image-based hematology analyzer systems.
IPC 8 full level
G01N 21/27 (2006.01); G01N 15/10 (2024.01); G01N 21/47 (2006.01); G01N 33/50 (2006.01); G01N 33/96 (2006.01); G01N 35/00 (2006.01); G01N 15/00 (2024.01)
CPC (source: EP US)
G01N 1/312 (2013.01 - EP); G01N 15/1012 (2013.01 - EP); G01N 15/1433 (2024.01 - EP); G01N 21/278 (2013.01 - EP); G01N 33/5094 (2013.01 - EP US); G01N 33/52 (2013.01 - US); G01N 33/96 (2013.01 - EP US); G01N 35/00029 (2013.01 - EP); G01N 35/00693 (2013.01 - EP); G01N 35/1002 (2013.01 - EP); G01N 15/01 (2024.01 - EP); G01N 21/4785 (2013.01 - EP); G01N 2015/012 (2024.01 - EP); G01N 2015/016 (2024.01 - EP); G01N 2015/018 (2024.01 - EP); G01N 2015/1006 (2013.01 - EP); G01N 2015/1014 (2024.01 - EP); G01N 2015/1486 (2013.01 - EP); G01N 2015/1493 (2013.01 - EP); G01N 2015/1497 (2013.01 - EP); G01N 2035/00138 (2013.01 - EP); G01N 2496/00 (2013.01 - EP)
Citation (search report)
- [X] WO 2014127372 A2 20140821 - THERANOS INC [US]
- [X] EP 0887637 A2 19981230 - BAYER AG [US]
- [X] WO 9735201 A1 19970925 - MARKMAN OFER [IL], et al
- [XY] US 2003142289 A1 20030731 - ORTYN WILLIAM E [US], et al
- [YD] US 2009269799 A1 20091029 - WINKELMAN JAMES [US], et al
- See also references of WO 2021127424A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2021127424 A1 20210624; CN 115087393 A 20220920; EP 4076183 A1 20221026; EP 4076183 A4 20240124; JP 2023508345 A 20230302; JP 7437510 B2 20240222; US 2023047416 A1 20230216
DOCDB simple family (application)
US 2020065997 W 20201218; CN 202080088225 A 20201218; EP 20903073 A 20201218; JP 2022538441 A 20201218; US 202017787125 A 20201218